Northern Trust’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-353,731
| Closed | -$49.5M | – | 4297 |
|
|
2018
Q4 | $49.5M | Sell |
353,731
-2,200
| -0.6% | -$334K | 0.01% | 860 |
|
|
2018
Q3 | $60.8M | Buy |
355,931
+30,574
| +9% | +$5.14M | 0.01% | 836 |
|
|
2018
Q2 | $56.4M | Buy |
325,357
+39,846
| +14% | +$5.99M | 0.01% | 899 |
|
|
2018
Q1 | $32.9M | Sell |
285,511
-122
| -0% | -$13K | 0.01% | 1321 |
|
|
2017
Q4 | $24M | Sell |
285,633
-2,890
| -1% | -$241K | 0.01% | 1573 |
|
|
2017
Q3 | $26.6M | Buy |
288,523
+30,782
| +12% | +$2.39M | 0.01% | 1498 |
|
|
2017
Q2 | $20.7M | Buy |
257,741
+45,272
| +21% | +$2.51M | 0.01% | 1648 |
|
|
2017
Q1 | $8.94M | Buy |
212,469
+46,628
| +28% | +$1.92M | ﹤0.01% | 2192 |
|
|
2016
Q4 | $5.33M | Buy |
165,841
+4,459
| +3% | +$114K | ﹤0.01% | 2511 |
|
|
2016
Q3 | $4.22M | Sell |
161,382
-3,666
| -2% | -$95.9K | ﹤0.01% | 2619 |
|
|
2016
Q2 | $3.83M | Buy |
165,048
+73,150
| +80% | +$1.82M | ﹤0.01% | 2639 |
|
|
2016
Q1 | $2.51M | Buy |
91,898
+2,348
| +3% | +$49.1K | ﹤0.01% | 2840 |
|
|
2015
Q4 | $2.55M | Buy |
89,550
+21,528
| +32% | +$578K | ﹤0.01% | 2902 |
|
|
2015
Q3 | $1.19M | Buy |
68,022
+27,434
| +68% | +$537K | ﹤0.01% | 3261 |
|
|
2015
Q2 | $732K | Buy |
40,588
+2,012
| +5% | +$27.5K | ﹤0.01% | 3441 |
|
|
2015
Q1 | $480K | Buy |
38,576
+1,310
| +4% | +$16.3K | ﹤0.01% | 3623 |
|
|
2014
Q4 | $438K | Buy |
+37,266
| New | +$434K | ﹤0.01% | 3586 |
|
Other funds holding LOXO
Northern Trust's LOXO Position: Q1 2019 in Review
Northern Trust sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 353,731 shares — an estimated $49.5M sold.
Northern Trust first reported a position in LOXO in Q4 2014 and held it in 17 quarters. The position peaked at $60.8M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Northern Trust reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Northern Trust sold 353,731 Loxo Oncology, Inc shares in Q1 2019, an estimated $49.5M.
- Northern Trust first reported a position in Loxo Oncology, Inc in Q4 2014 and held it in 17 quarters.
- Northern Trust's Loxo Oncology, Inc position peaked at $60.8M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Northern Trust's 13F filing for Q1 2019, filed 13 May 2019.